RPG Life Sciences Limited · NSE: RPGLIFE · BSE: 532983
RPG Life Sciences
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 28 Jul 2026.
Q1 FY27 · Consolidated
Revenue
195.69₹ Cr
— vs year ago
Net profit
30.76₹ Cr
— vs year ago
EPS, basic
18.60₹
— vs year ago
Net margin
15.7%
— vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 195.69 | — | 30.76 | — | 18.60 | 28 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 176.89 | — | 29.90 | — | 18.08 | 29 Apr 2026 |
| Q3 FY26Oct–Dec 2025 | 180.03 | — | 22.13 | — | 13.38 | 27 Jan 2026 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 195.69 | +15.8% | 30.57 | +16.3% | 18.49 | 28 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 176.89 | +23.6% | 29.90 | −74.5% | 18.08 | 29 Apr 2026 |
| Q3 FY26Oct–Dec 2025 | 180.03 | +4.2% | 22.13 | −36.6% | 13.38 | 27 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 181.68 | +5.5% | 36.85 | +777.4% | 22.28 | 17 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 168.92 | +2.1% | 26.29 | −1.8% | 15.90 | 25 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 143.09 | +12.7% | 117.35 | +786.3% | 70.96 | 28 Apr 2025 |
| Q3 FY25Oct–Dec 2024 | 172.71 | +12.4% | 34.93 | +32.0% | 21.12 | 24 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 172.21 | +12.1% | 4.20 | −83.8% | 2.54 | 07 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 165.42 | +11.9% | 26.76 | +21.1% | 16.18 | 20 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 126.99 | +7.2% | 13.24 | +27.9% | 8.01 | 08 May 2024 |
| Q3 FY24Oct–Dec 2023 | 153.70 | +17.7% | 26.46 | +38.5% | 16.00 | 16 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 153.58 | +13.9% | 25.86 | +29.5% | 15.64 | 25 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 147.78 | +14.6% | 22.10 | +21.4% | 13.36 | 28 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 118.49 | +14.2% | 10.35 | +37.6% | 6.26 | 09 May 2023 |
| Q3 FY23Oct–Dec 2022 | 130.60 | +13.0% | 19.11 | +30.6% | 11.56 | 07 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 134.79 | +19.7% | 19.97 | +26.8% | 12.08 | 19 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 128.93 | +19.2% | 18.21 | +34.1% | 11.01 | 05 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 103.80 | +11.9% | 7.52 | +8.7% | 4.55 | 10 May 2022 |
| Q3 FY22Oct–Dec 2021 | 115.58 | +7.4% | 14.63 | +13.7% | 8.85 | 27 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 112.65 | +16.0% | 15.75 | +41.3% | 9.52 | 01 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 108.13 | +18.0% | 13.58 | +49.9% | 8.21 | 28 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 92.76 | +4.6% | 6.92 | +132.2% | 4.18 | 04 May 2021 |
| Q3 FY21Oct–Dec 2020 | 107.60 | +14.0% | 12.87 | +62.7% | 7.78 | 25 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 97.13 | −1.4% | 11.15 | +14.1% | 6.74 | 06 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 91.65 | −2.5% | 9.06 | +8.5% | 5.48 | 06 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 88.67 | +28.9% | 2.98 | +93.5% | 1.80 | 06 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 94.37 | +3.7% | 7.91 | +49.8% | 4.78 | 01 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 98.49 | +8.8% | 9.77 | +352.3% | 5.91 | 31 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 94.04 | +17.7% | 8.35 | +356.3% | 5.05 | 31 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 68.80 | — | 1.54 | — | 0.93 | 30 Apr 2019 |
| Q3 FY19Oct–Dec 2018 | 90.97 | — | 5.28 | — | 3.19 | 06 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 90.50 | — | 2.16 | — | 1.31 | 10 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 79.89 | — | 1.83 | — | 1.11 | 30 Jul 2018 |
36 filings on record for this company.